Results 13,341-13,360 of 21,090 for speaker:Alan Kelly

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: I am specifically asking about the HSE and SCA. How many times have they met following Scally's recommendations?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: Would it be unusual if they had not discussed it?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: Who is that lady?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: What is her title? What does she do?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: That is helpful. I have a follow-up question for clarity. We spoke about colposcopy clinics which receive notifications of abnormalities. There is an obvious increase in demand. We had a lot of discussion here previously about colposcopists and we are still looking for some minutes, which we have never found, for the famous second meeting. Are there issues that we need to know about? We...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: It does not matter.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: I think that needs to be dialled up. I am just getting information. We all know that we are discussing this, by and large, because of the amazing Vicky Phelan and her refusal to sign a non-disclosure agreement. Since her case, have there been issues with confidentiality or people being asked to sign non-disclosure agreements? Is that just gone?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: I just wanted to make sure it has not happened since Mr. Breen was last here.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: I have a final few questions. I am trying to be exhaustive. This question is for the HSE though I am not sure who wants to answer. After the Scally report, and before it in fairness, since I do not want to misrepresent him, the acting chief executive officer, John Connaghan, said that he would not be shy about looking into what Dr. Scally reported regarding internal decision-making and...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: That is the most important part. The 50 recommendations are by far the most important element of the report.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: I am not sure that answers my question.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: Obviously I understand everything that Mr. McCallion has said but there is a requirement to figure out with why things happened as they did and "institutional failure" is just too fluffy. I am not picking on anyone when I say that. We need to find out why things happened in the way they did and Mr. McCallion said that he would do that. He possibly cannot answer my question now but I am...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: If there is no figure, that is even more worrying.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: Yes, but there must be a figure. This country is not run on the basis of just doing things and worrying about the costs later. If there is no figure available today, that is even more worrying. I must stress that I am not criticising the Minister for the commitment he gave. In fact, had any of us been in his position at the time, we would probably have made the same decision. I do not...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: Where does this leave us?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: I do not know where to go with this. I have asked a pretty obvious question. I am not having a go at anyone. Perhaps the witnesses could write to the committee giving more information on the costs of the programme to date.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: Would that be fair?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: I do not want to be unfair. My next question is for the Department. The Minister has made a commitment that there will be two patient advocates on boards, which is only right and proper, particularly with regard to the board of the HSE which is being reinstated. That board should never have been abolished. In my view, we need to take a different approach to finding such people. We need...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

Alan Kelly: I thank the witnesses for their input which has been quite good.

Written Answers — Department of Finance: Tax Code (13 Nov 2018)

Alan Kelly: 157. To ask the Minister for Finance if he has announced, or his plans to announce, changes to capital gains tax or capital acquisitions tax regarding solar panels on farmland as part of budgetary measures; and if he will make a statement on the matter. [46658/18]